NSC |
Compound |
Enrichment |
Correlation |
NSC 363787 |
Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- |
0.0403978426119736 |
0.65189613 |
NSC 625502 |
Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, |
0.0403978426119736 |
0.67275286 |
NSC 631136 |
Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- |
0.0403978426119736 |
0.72154976 |
NSC 633271 |
Null |
0.0403978426119736 |
0.67138888 |
NSC 687980 |
Null |
0.0403978426119736 |
0.20461286 |
NSC 730473 |
16-[3-Methoxy-4-(2-piperidin-1-yl ethoxy)benzylidene]-5-androstene-3b,17b-diol diacetate |
0.0403978426119736 |
-0.20232702 |
NSC 639514 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride |
0.040397842611974 |
0.64824616 |
NSC 639541 |
Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- |
0.040397842611974 |
0.64814512 |
NSC 641245 |
Benzenebutanamide, N-(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)-.alpha.,.gamma.-dioxo-2-(3,4-dihydro- 3,4-dioxo-2-naphthalenyl)- |
0.040397842611974 |
0.42748298 |
NSC 646159 |
Null |
0.040397842611974 |
0.68165632 |